Subscribe: Market Wire - Pharmaceuticals and Biotech: Biotech
http://img.marketwire.com/rss/mwPBBI.rss
Preview: Market Wire - Pharmaceuticals and Biotech: Biotech

Marketwired - Biotech



Marketwired - Biotech



Last Build Date: Wed, 22 Nov 2017 17:33:56 EST

Copyright: Copyright: (C) Marketwired
 



Tetra Bio-Pharma's Business Model and Commercialization Strategy In Line with the Canadian Government's Proposed Approach to the Regulation of Cannabis

Wed, 22 Nov 2017 17:02:10 EST

OTTAWA, ONTARIO--(Marketwired - Nov. 22, 2017) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that the Canadian Government's Proposed Approach to the Regulation of Cannabis further confirms the strategic direction of its business model, and that the company is in an excellent position to commercialize natural health products and drugs post-legalization for both the pet and human markets.




U.S. FDA Advisory Panel Meetings: Strategies to Maximize Success, New Webinar Hosted by Xtalks

Wed, 22 Nov 2017 15:47:38 EST

TORONTO, ON--(Marketwired - November 22, 2017) - Often, US Food & Drug Administration (FDA) Advisory Panel meetings are the capstone to what is characteristically a long and arduous medical device development journey. While these meetings typically close with a voting session on a medical device's approvability, recent real-world experiences demonstrate that achieving a favorable set of panel votes does not always guarantee swift FDA approval of the medical device under consideration.




Kiwa Bio-Tech Files Restated Financial Statements

Wed, 22 Nov 2017 14:53:05 EST

ONTARIO, CA--(Marketwired - Nov 22, 2017) - Kiwa Bio-Tech Products Group Corporation (OTCQB: KWBT) ("Kiwa Bio-Tech" or the "Company") announced that on November 22, 2017, following a re-audit of Kiwa Bio-Tech's Annual Financial Statement for the year ended December 31, 2016 by Friedman LLP, the Company's new independent registered public accounting firm, Kiwa Bio-Tech filed an amended Annual Report on Form 10-K/A (the "Amended Annual Report") with the Securities and Exchange Commission for the year ended December 31, 2016. The Amended Annual Report incorporates restated financial statements which properly account for all matters which were the subject of the prior conclusion that the Annual Report should no longer be relied upon. Such restatements resolve all issues which were the basis of the Company's prior advice that the originally filed Annual Report should no longer be relied upon.




Jacobson Pharma Announces FY2018 Interim Results

Wed, 22 Nov 2017 09:55:24 EST

Realizing Growth Strategies With Both Revenue and Net Profit Up; Declares Interim Dividend of HK0.9 cent per share




Northern Vine Labs Combines the Best of Abattis and Emerald Health -- CFN Media

Wed, 22 Nov 2017 09:53:13 EST

SEATTLE, WA--(Marketwired - Nov 22, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering the partnership between Abattis Bioceuticals Corp. (CSE: ATT) (CNSX: ATT) (CNSX: ATT.CN) (OTCQB: ATTBF) and Emerald Health Therapeutics Inc. (TSX VENTURE: EMH) (OTCQX: EMHTF) to run Northern Vine Laboratories as a joint venture, which promises to take advantage of a growing market for lab testing and extract products.




NetworkNewsWire Announces Publication on Investment Capital Pouring into Canada's Legal Cannabis Market

Wed, 22 Nov 2017 08:30:00 EST

NEW YORK, NY--(Marketwired - Nov 22, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ABcann Global Corp. (OTCQB: ABCCF) (TSX VENTURE: ABCN), a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis and one of the earliest licensed Canadian medical marijuana producers.




Delivra Announces Record Sales Growth for the Quarter

Wed, 22 Nov 2017 07:00:00 EST

TORONTO, ON--(Marketwired - November 22, 2017) - Delivra Corp. (TSX VENTURE: DVA) ("Delivra" or the "Company") reported its financial results for the three and nine months ended September 30, 2017. All figures are reported in CDN dollars ($), unless otherwise indicated. Delivra's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").




ESMO Celebrates Successful Completion Of 3rd ESMO Asia Congress In Singapore

Tue, 21 Nov 2017 21:00:00 EST

The momentum continues as experts around the world gather to advance cancer care




Cannabis Science Finalizes Acquisition of its First PRE ICO Dispensary in Los Angeles, California and Continues Negotiations to Close the Second Los Angeles Area Medical Marijuana Dispensary

Tue, 21 Nov 2017 11:29:51 EST

IRVINE, CA--(Marketwired - Nov 21, 2017) -  Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that its expansions plans are well underway as it has signed agreements to acquire and officially open the first Cannabis Science PRE ICO Medical Marijuana dispensary, in Los Angeles, California.




The Alliance for Regenerative Medicine Releases Q3 2017 Data Report, Highlighting Sector Trends and Metrics

Tue, 21 Nov 2017 10:57:39 EST

WASHINGTON, DC--(Marketwired - Nov 21, 2017) - The Alliance for Regenerative Medicine (ARM) released today its most recent quarterly data report, offering an in-depth look at cell therapy, gene therapy, tissue engineering and broader global regenerative medicine sector trends and metrics in the third quarter of 2017.




NetworkNewsWire Announces Publication on Recreational Marijuana and How Canada's Producers are Rising to Meet Demand

Tue, 21 Nov 2017 08:30:00 EST

NEW YORK, NY--(Marketwired - Nov 21, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ABcann Global Corp. (OTCQB: ABCCF) (TSX VENTURE: ABCN), a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis and one of the earliest licensed Canadian medical marijuana producers.




Pieris Pharmaceuticals Appoints James Geraghty as Chairman of the Board of Directors

Tue, 21 Nov 2017 08:30:00 EST

BOSTON, MA--(Marketwired - November 21, 2017) - Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for cancer, respiratory and other diseases, announced today that James Geraghty has been appointed Chairman of the Board of Directors. Mr. Geraghty replaces Chau Q. Khuong, who is stepping down from the Board after helping guide Pieris through platform validation and partnerships to its transition into a fully-integrated research and clinical development company.




ViaDerma, Inc. is Granted Approval to sell VitaStem(TM) its FDA Registered Topical Antibiotic on Amazon.com and Expands Testing into Major US Hospital Chains to Ramp Up Domestic Sales & Begins Production of New Products

Tue, 21 Nov 2017 08:12:24 EST

ViaDerma's Manufacturer Delivered the first run of its topical antibiotic being sold as VitaStem by its Sales, Marketing and Distribution Partner Biogenx, Inc.; The Company will now start Producing New Products for Distribution in 400 Retail Stores in Canada for its CBD or Cannabinoids Product Line




Moleculin to Present at the 10th Annual LD Micro Main Event on December 5, 2017 at 11:30 a.m. PT

Tue, 21 Nov 2017 07:30:00 EST

Company will present on Tuesday, December 5, 2017 at 11:30 a.m. PT (2:30 p.m. ET)




Global Medical Information System: Characteristics & Implementation Approach, New Webinar Hosted by Xtalks

Tue, 21 Nov 2017 07:30:00 EST

TORONTO, ON--(Marketwired - November 21, 2017) - In a live session upcoming on Wednesday, December 6, 2017, Techsol, a global leader in life sciences, will present a webinar that will examine key characteristics of a global medical information management system and the critical factors that drive an optimized implementation and deployment strategy.




Revive Therapeutics Appoints Blockchain Expert, Bernie Doyle, as Technical Advisor to Support Development of Medical Cannabis Patient-Focused Program Enabled by Blockchain and AI Technology

Tue, 21 Nov 2017 07:00:00 EST

TORONTO, ONTARIO--(Marketwired - Nov. 21, 2017) - Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE:RVV)(OTCQB:RVVTF), a company focused on the research, development and commercialization of novel therapies and technologies for the medical cannabis and pharmaceutical sectors, today announced that Mr. Bernie Doyle will join the Company as a Technical Advisor to support the development of the Company's proposed proprietary patient-focused program enabled by blockchain and artificial intelligence ("AI") dedicated to the medical cannabis sector.




When Is Central Imaging Needed in Clinical Trials? New Webinar Hosted by Xtalks

Tue, 21 Nov 2017 07:00:00 EST

TORONTO, ON--(Marketwired - November 21, 2017) - On Wednesday, December 6, 2017 Xtalks will host a webinar that summarizes and highlights the various types of imaging and their role in the clinic and in research, with a perspective on the regulatory aspects that govern its use and practical aspects for pharma, biotech and contract research organizations.




SANUWAVE Health Reports Third Quarter Financial Results and Provides a Business Update

Mon, 20 Nov 2017 18:12:07 EST

SUWANEE, GA--(Marketwired - Nov 20, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results for the three and nine months ended September 30, 2017 on November 14 2017 and will provide a business update on a conference call at 10:00AM Eastern Time on Tuesday, November 21, 2017. 




Sirona Biochem Announces Grant of Stock Options

Mon, 20 Nov 2017 17:38:46 EST

VANCOUVER, BC--(Marketwired - November 20, 2017) - Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) (XETRA: ZSB) (the "Company") announces that it has granted an aggregate of 2,350,000 bonus and incentive stock options to management, independent directors and consultants of the Company. The options, to purchase common shares in the capital of the Company at a price of $0.15 per common share, will be for a period of 10 years for management and 5 years for independent directors and consultants. Periods end November 20, 2027 and November 20, 2022 respectively. The options have been granted under the terms of the Company's stock option plan.




Rennova Health Reports Third Quarter 2017 Financial Results

Mon, 20 Nov 2017 16:45:00 EST

WEST PALM BEACH, FL --(Marketwired - November 20, 2017) - Rennova Health, Inc. (OTCQB: RNVA) (OTCQB: RNVAW), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that opened its first rural hospital in Oneida, Tennessee on August 8, 2017, reports financial results for the three and nine months ended September 30, 2017 and provides a business update.




Deciphering the Complexity of the Acute Leukemia Immunological Microenvironment with 3D Biology(TM) Technology, New Webinar Hosted by Xtalks

Mon, 20 Nov 2017 12:07:52 EST

TORONTO, ON--(Marketwired - November 20, 2017) - Join the live session on Tuesday, December 5, 2017 at 12pm EST to learn more about how the combined analysis of SNV, mRNA, and protein expression on the nCounter system enabled a comprehensive characterization of the molecular landscape of leukemia cells. Guest speakers include Doug Hinerfeld, Ph.D., Principal Product Application Scientist at NanoString Technologies, and Sergio Rutella, M.D., Ph.D., Professor of Cancer Immunotherapy, at John van Geest Cancer Research Centre, Nottingham Trent University.




mCig's eHesive Advertising Network Signed an Exclusive Agreement with Hosting Company FlameNetworks

Mon, 20 Nov 2017 09:56:52 EST

LAS VEGAS, NV--(Marketwired - Nov 20, 2017) - mCig, Inc. (OTCQB: MCIG), a diversified company servicing the legal cannabis markets, announced today that the company has entered into an agreement between OBITX, Inc., formerly known as GigeTech, Inc., a wholly owned subsidiary of MCIG and FlameNetworks to implement the proprietary eHesive Advertising Network with an Exclusive territory as an EU partner.




Advanced Proteome Therapeutics Expands Antibody-Drug Conjugate Collaboration

Mon, 20 Nov 2017 08:00:00 EST

VANCOUVER, BC--(Marketwired - November 20, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC) (FRANKFURT: 0E8) a biotechnology company focused on developing superior targeted protein therapeutics, is expanding the collaboration with the National Research Council of Canada (NRC) and receiving support from its Industrial Research Assistance Program (NRC IRAP) to conduct key steps in development of APC's novel technology.




SanSal Wellness Holdings, Inc. Positioned to Leverage World-Class Agribusiness and Hemp Cultivation Management and Operations Team

Mon, 20 Nov 2017 08:00:00 EST

FORT LAUDERDALE, FL--(Marketwired - Nov 20, 2017) - SanSal Wellness Holdings, Inc. ("SanSal Wellness" or the "Company") (OTC PINK: SSWH), a vertically-integrated agribusiness focused on producing full spectrum natural phytocannabinoid-rich industrial hemp extracts, today provided shareholders and the investment community with an update detailing its world-class management and operations team.




Trillium Therapeutics' TTI-2341 EGFR Inhibitor Program Featured at the Society for Neuro-Oncology 22nd Annual Meeting

Mon, 20 Nov 2017 07:00:00 EST

TORONTO, ONTARIO--(Marketwired - Nov. 20, 2017) - Trillium Therapeutics Inc. (NASDAQ:TRIL)(TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, announced today that new preclinical data for its novel covalent EGFR inhibitor were presented at the Society for Neuro-Oncology 22nd Annual Meeting, November 16-19, in San Francisco.




Improving Regulatory and Operational Performance in Orphan Drug Development, a New Webinar Presented by Premier Research and Hosted by Xtalks

Mon, 20 Nov 2017 07:00:00 EST

TORONTO, ON--(Marketwired - November 20, 2017) - Today more than ever, regulatory bodies are providing a progressive platform for rare disease drug development. Extensions to existing regulations and incentives and attempts to reduce orphan drug designation applications provide a collaborative environment for companies developing orphan drugs.




Angle PLC: Holding(s) in Company

Fri, 17 Nov 2017 12:03:26 EST

GUILDFORD, SURREY--(Marketwired - Nov 17, 2017) -  Angle PLC (AIM: AGL) (OTCQX: ANPCY)




CFN Media Exclusive Onsite CEO Interview with Lifestyle Delivery Systems: Up and Running in a $5 Billion Market

Fri, 17 Nov 2017 09:00:00 EST

SEATTLE, WA--(Marketwired - Nov 17, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an exclusive CEO interview and article covering Lifestyle Delivery Systems Inc. (CSE: LDS) (CNSX: LDS) (LDS.CN) (OTCQB: LDSYF), its new state of the art facility in Adelanto, California, and the potential for the company as California implements new regulations for adult-use of marijuana.




Future Farm Partners with Israeli Company to Develop Elite Cannabis Clones -- CFN Media

Fri, 17 Nov 2017 09:00:00 EST

SEATTLE, WA--(Marketwired - Nov 17, 2017) -  CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing the need to develop a wide variety of standardized cannabis plants for a vast array of potential applications, and the efforts of Future Farm Technologies Inc. (CSE: FFT) (CNSX: FFT) (CN.FFT) (OTCQB: FFRMF) to solve the problem.




Cerecor Announces Leadership Changes

Fri, 17 Nov 2017 08:30:00 EST

Appoints Randal O. Jones and Robert C. Moscato, Jr. to Board of Directors; Names Moscato as President and Chief Operating Officer

Interim chief executive officer John Kaiser and chief medical officer Dr. Ronald Marcus stepping down

Changes follow pivotal acquisition of TRx Pharmaceuticals guiding transformation toward pediatric health company




Cerecor Acquires TRx Pharmaceuticals

Fri, 17 Nov 2017 08:15:00 EST

Addition of commercial franchise signals strategic shift toward pediatric healthcare

Revenue stream to drive development of early-stage orphan drug candidates




Cosmos Holdings, Inc. Announces $3 Million Securities Purchase Agreement With Two Institutional Investors

Thu, 16 Nov 2017 14:01:17 EST

CHICAGO, IL--(Marketwired - Nov 16, 2017) - Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has entered into a $3 million securities purchase agreement with two institutional investors.




Aequus Granted European Patent for Once-Weekly Transdermal Aripiprazole

Thu, 16 Nov 2017 09:43:44 EST

VANCOUVER, BC--(Marketwired - November 16, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today that the European Patent Office has issued an intention to grant a European patent for AQS1301, Aequus' once-weekly transdermal patch containing aripiprazole. AQS1301 is in development for the treatment of certain psychiatric disorders and is intended to provide patients with a long-acting dosing alternative that is a comfortable, convenient and easy-to-use in an effort to promote medication adherence.




The Sequoia Project's Annual Meeting to Draw Health IT Leaders Nationwide to Discuss Data Sharing Progress and the Path Forward

Thu, 16 Nov 2017 09:28:07 EST

Event to be held December 5-6 in Gaylord National Harbor, Maryland




SANUWAVE Health to Host Upcoming Clinical and Science Symposium on Advanced Wound Care

Thu, 16 Nov 2017 09:00:00 EST

SUWANEE, GA--(Marketwired - Nov 16, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) today announces the Company's planned Clinical and Science Symposium on Advanced Wound Care to be held on December 8 and 9, 2017, in Atlanta, GA. This event will gather SANUWAVE's clinical researchers, science advisors, Key Opinion Leaders, and world-wide distributors to discuss extracorporeal shockwave technology as an advanced modality in the wound care field, its current applications in the medical field, and future applications in wound care and other medical needs. Medical professionals and distributors will be attending from Taiwan, Italy, Brazil, and South Korea as well as medical advisors from the U.S. SANUWAVE is pleased to have among its presenters Dr. Maria Siemionow, Professor of Orthopedics and Director of Microsurgery Research at the University of Illinois at Chicago College of Medicine and Dr. Ching-Jen Wang, Professor of Orthopaedic Surgery at the Chang Gung University College of Medicine and Chang Gung Memorial Hospital, Taiwan.




NetworkNewsWire Announces Publication Outlining Innovations Driving Value in Cannabis Industry

Thu, 16 Nov 2017 08:30:00 EST

NEW YORK, NY--(Marketwired - Nov 16, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems.




NetworkNewsWire Announces Publication Featuring Challenges Facing Canada's Licensed Producers as Recreational Cannabis Market Looms

Thu, 16 Nov 2017 08:30:00 EST

NEW YORK, NY--(Marketwired - Nov 16, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ABcann Global Corp. (OTCQB: ABCCF) (TSX VENTURE: ABCN), a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis and one of the earliest licensed Canadian medical marijuana producers.




Cannabis Science Set to Launch its Online Community for Doctors, Patients, Industry Professionals Worldwide to Share Experiences and Expertise Using Cannabinoid Therapies for Various Critical Ailments, Palliative Care and Related Information

Thu, 16 Nov 2017 08:05:57 EST

IRVINE, CA--(Marketwired - Nov 16, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is proud to announce that next week the company will release its newest version of the Patient Access Center (PAC), an exclusive online community for social networking and information sharing platform. By bringing together Doctors, Patients, Industry Professionals, Lawyers, Scientists, Civil and Constitutional Rights Activists, Legalization Efforts Groups and many others, we are building a powerful knowledge center of real world data of successful treatment stories, formal clinical study information, to mobilizing large groups for upcoming events, or certain demographics that need help to help effective change for each area of concern or question.




SanSal Wellness Holdings, Inc. Highlights Whole-Plant Hemp Oil Extraction Operations and Growth Opportunities

Thu, 16 Nov 2017 08:00:00 EST

FORT LAUDERDALE, FL--(Marketwired - Nov 16, 2017) - SanSal Wellness Holdings, Inc. ("SanSal Wellness" or the "Company") (OTC PINK: SSWH), a vertically-integrated agribusiness focused on producing full spectrum natural phytocannabinoid-rich industrial hemp extracts, today provided shareholders and the investment community with an update highlighting its current operations, business strategy, and growth opportunities in the rapidly expanding market for industrial hemp and whole-plant hemp oil extracts in the USA and internationally.




BioCorRx Provides Business Update for the Third Quarter of 2017

Thu, 16 Nov 2017 08:00:00 EST

Investor Call to be held on Friday, November 17th at 2:00 PM ET




Tetra Bio-Pharma Inc.: Rx Princeps(TM) Now Available for Patients through Licenced Producer Partner Aphria

Thu, 16 Nov 2017 07:30:50 EST

OTTAWA, ONTARIO--(Marketwired - Nov. 16, 2017) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that Rx PrincepsT, unique blend of dried medical cannabis used in its PPP001 clinical trials, is now available through licensed producer Aphria Inc. ("Aphria") under Access to Cannabis for Medical Purposes Regulations (ACMPR).




Zenosense, Inc.: MIDS Hybrid Strip - Successful Initial Test Results

Thu, 16 Nov 2017 07:30:00 EST

VALENCIA, SPAIN--(Marketwired - Nov 16, 2017) - Zenosense, Inc. (OTC PINK: ZENO) ("Zenosense", the "Company"), a healthcare technology company primarily focused on the development and commercialization of MIDS CardiacT, a Point of Care ("POC") handheld device for the early detection of certain cardiac event biomarkers to significantly accelerate the triage, diagnosis, treatment and disposition of patients reporting chest pain and with suspected acute myocardial infarction (heart attack), is pleased to announce that its MIDS Medical Limited joint venture ("MML") based at Sci-Tech, Daresbury (UK), has successfully completed initial testing of its "Hybrid Strip" system.




Angle PLC: Total Voting Rights and Covington Subscription

Thu, 16 Nov 2017 04:26:57 EST

GUILDFORD, SURREY--(Marketwired - Nov 16, 2017) - Angle PLC (OTCQX: ANPCY) (AIM: AGL)